Cost-effectiveness of the Adaptive Implementation of Effective Programs Trial (ADEPT): approaches to adopting implementation strategies

Table 2 Base case analysis results

Condition	Cost per patient	Effectiveness	ICER^a	NMB^b
Utility: QALYS
Baseline (REP only)	588.95	0.47	0	46911.05
REP+EF only	637.53	0.48	Dominated^c	47822.00
REP+EF, add IF if needed	627.40	0.54	593.42^d	53351.18
REP+EF/IF	625.95	0.47	Dominated^c	45987.68

^aICER: incremental cost-effectiveness ratio
^bNMB: net monetary benefit. Willingness-to-pay threshold $100,000/QALY [45]
^cDominated: more expensive and less effective than comparators [46]
^dSince “REP+EF/IF” is dominated, “REP+EF, add IF if needed” is compared to REP only

ISSN: 1748-5908